Abipha commenced construction of GMP-WHO pharmaceutical factory

Abipha commenced construction of GMP-WHO pharmaceutical factory

Established in 2011, during the process of production and business development, Abipha International Pharmaceutical Joint Stock Company has constantly developed and researched various products to serve the needs of healthcare services and manufacturing from outsourcing partners.

With our desire to be proactive in the production of many dosage forms, packing and to develop quality products, which are effectively similar to imported products, Abipha has invested in constructing a factory that manufactures pharmaceuticals, health supplements, cosmetics complying with GMP-WHO standards, and is expected to operate in the third quarter of 2018.

Abipha khởi công xây dựng nhà máy sản xuất dược phẩm GMP-WHO

Mr. Trinh Dinh Anh – Chairman of the Board of Directors and CEO gave the opening speech

Recognizing that Vietnam’s pharmaceutical market still has many opportunities, the Vietnamese can use domestic products, with international quality, reasonable prices, now Abipha has set up a number of modern production lines such as hard capsules, soft gels, powder, syrup and had certain successes over a period of 6 years.

Fresh bouquets of flowers were sent to the company from our long-term partners who share great and sustainable cooperation with Abipha. Mr. Trinh Dinh Anh and the CEO of Abipha CNC factory Mr. Nguyen Truong Lap on behalf of the company leadership received flowers from guest. On December 5th, 2017, at Lot CN2, Phu Nghia Industrial Zone, Chuong My, Hanoi, Abipha International Pharmaceutical Joint Stock Company held a ceremony to build the factory according to GMP –WHO standard with the presence of the Management Board of the industrial park, banks, partners, customers, and authorized agencies in the area.

Abipha obtained a license to build factory No. 1073 / GPXD by Hanoi Export Processing and Industrial Zones Authority on July 7th, 2017 with 07 buildings, namely:

On this land of 18,000 m2 in a few more months…

There will be a leading pharmaceutical factory in Vietnam

Building No. 1: 6-floor office building and a basement – construction area of 615 m2 each floor, total construction area of 3,690 m2. The office includes a Quality control department that meets GLP and ISO 17025 standards and a Research & Development center capable of researching products that meet international standards.

Building No. 2: Production area for pharmaceuticals, herbal extraction system and warehouse, cosmetics: total construction area of 4,635 m2.

Building No. 3: Warehouse: construction area of 1,518 m2.

Building No. 4: Pharmaceutical production area, including production lines of Betalactam, Non Betalactam products, eye drop products: Construction area of 3,000 m2. Total floor area of 3,129 m2.

Building No. 5: GMP-complied production area for health supplements, Construction area of 1,656 m2, total floor area of 2,484 m2.

Building No. 6 and No. 7: pharmaceutical utility systems and security office, respectively; total construction area of 356 m2, total floor area of 572 m2 .The factory is divided into 02 phases with a total investment of basic construction of about 450-500 billion VND (19 – 21.5 million USD).

We expect that the factory’s operation will help Abipha become one of the pharmaceutical enterprises in Vietnam with a wide range of modern and advanced production lines, contributing to serving the needs of the blooming pharmaceutical market.

Gửi ý kiến

Your email address will not be published.